1. Trial Watch.
- Subjects
- *
T cells , *KILLER cells , *CANCER patients , *CELL proliferation , *DENDRITIC cells , *NATURAL immunity , *IMMUNE response , *INFLAMMATION - Abstract
The article focuses on a research paper investigating whether it is possible to induce antitumor responses in vivo in cancer patients by activating natural killer T (NKT) cells, which are induced to proliferate by dendritic cells. The patients experienced temporary inflammatory symptoms as well as respiratory symptoms in individuals with pulmonary metastases. The study offers clinical evidence that NKT cells can bridge innate and acquired immunity to induce secondary antitumor immune responses.
- Published
- 2004
- Full Text
- View/download PDF